ICON Plc (ICLR) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

ICON plc (ICON) is a contract research organization (CRO) that provides outsourced development services to the biotechnology, pharmaceutical and medical device industries worldwide. It provides a range of specialized services that span the entire lifecycle of product development. The companys service portfolio includes adaptive trials, biosimilars, clinical research services, commercialization and outcomes, consulting, functional services provision, medical imaging, laboratory services, resourcing solutions and strategic support and tactical solutions for traditional, in vitro diagnostic, and software devices. The company offers research services in areas such as cancer, genomics, central nervous system, cardiovascular, endocrine and metabolic disorders, gastrointestinal, medical device, nonalcoholic steatohepatitis (NASH), ophthalmology, rare and orphan diseases, transplant and immunology, vaccines, womens health therapeutics and other therapeutic areas. ICON is headquartered in Dublin, Ireland.

ICON Plc (ICLR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 5
List of Figures 5
ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
ICON Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
ICON Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
ICON Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
ICON Plc, Medical Devices Deals, 2012 to YTD 2018 10
ICON Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
ICON Plc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Icon Completes Acquisition Of Clinical Trial Services Business From Cross Country Healthcare For Up To US$56 Million 12
Venture Financing 13
Aptiv Solutions Raises US$5.7 Million In Venture Financing 13
Merger 14
Inclinix Merges With PMG Research 14
Licensing Agreements 15
Aptiv Solutions Enters Into Licensing Agreement With Tessella For FACTS, Adaptive Trial Design Software 15
Debt Offering 16
ICON Raises USD350 Million in Private Placement of 3.64% Notes Due 2020 16
Acquisition 17
ICON Acquires Mapi 17
Icon Acquires Clinical Research Management 18
Icon Acquires PMG Research from Frontier Capital 19
ICON Acquires MediMedia Pharma Solutions for USD120 Million 20
Icon Completes Acquisition Of Aptiv Solutions For US$143.5 Million 21
Icon Completes Acquisition Of BeijingWits Medical Consulting, Contract Research Organization 23
ICON Plc - Key Competitors 24
ICON Plc - Key Employees 25
ICON Plc - Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 29
Strategy And Business Planning 29
Mar 29, 2018: ICON Helps Establish New Industry Standards Group to Improve Clinical Trial Collaboration and Execution 29
Mar 14, 2018: ICON opens a new office in Boston 30
Financial Announcements 31
May 02, 2018: ICON Reports First Quarter 2018 Results 31
Feb 15, 2018: ICON Reports Fourth Quarter and Full Year 2017 Results 32
Jan 09, 2018: ICON Issues Financial Guidance for Full Year 2018 34
Oct 26, 2017: ICON Reports Third Quarter 2017 Results 35
Jul 27, 2017: ICON Reports Second Quarter 2017 Results 36
Apr 27, 2017: ICON Reports First Quarter 2017 Results 37
Feb 16, 2017: ICON Reports Fourth Quarter and Full Year 2016 Results 38
Jan 09, 2017: ICON Issues Financial Guidance for Full Year 2017 39
Corporate Communications 40
Jan 09, 2018: ICON Appoints Dr. James Cummings as President of ClinicalRM 40
Nov 17, 2017: ICON Announces Appointment of Ms. Joan Garahy to Board of Directors 41
Oct 04, 2017: ICON Announces Appointment of Mr. Eugene McCague to Board of Directors 42
Government and Public Interest 43
Mar 27, 2018: Leading CROs Form New Industry Standards Group to Improve Collaboration with Sponsors 43
Product News 45
Nov 21, 2017: ICON Launches FIRECREST Pre-Screen to Improve the Speed and Accuracy of Identifying Eligible Patients for Screening 45
Nov 07, 2017: ICON contributes to major European research study that aims to improve treatment for traumatic brain injury 46
Feb 20, 2017: ICON Selected by the FDA to Validate Patient-Reported Outcome Endpoints for Antibacterial Drug Trials 47
Other Significant Developments 48
Jun 22, 2018: ICON and DIA driving Insights to Action with DIA Live 2018 48
Apr 03, 2018: ICON announces launch of Government and Public Health Solutions to support global public health 49
Nov 21, 2017: FIRECREST Pre-Screen improves sponsor visibility of patient access 50
Nov 06, 2017: ICON Reveals Voice-Assistant Applications for Clinical Trials at ISPOR Annual European Congress 51
Oct 27, 2017: ICON and ICHOM unveil the worlds first global patient outcomes benchmarking platform 52
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53

List Of Tables

List of Tables
ICON Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
ICON Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
ICON Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
ICON Plc, Deals By Therapy Area, 2012 to YTD 2018 9
ICON Plc, Medical Devices Deals, 2012 to YTD 2018 10
ICON Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Icon Completes Acquisition Of Clinical Trial Services Business From Cross Country Healthcare For Up To US$56 Million 12
Aptiv Solutions Raises US$5.7 Million In Venture Financing 13
Inclinix Merges With PMG Research 14
Aptiv Solutions Enters Into Licensing Agreement With Tessella For FACTS, Adaptive Trial Design Software 15
ICON Raises USD350 Million in Private Placement of 3.64% Notes Due 2020 16
ICON Acquires Mapi 17
Icon Acquires Clinical Research Management 18
Icon Acquires PMG Research from Frontier Capital 19
ICON Acquires MediMedia Pharma Solutions for USD120 Million 20
Icon Completes Acquisition Of Aptiv Solutions For US$143.5 Million 21
Icon Completes Acquisition Of BeijingWits Medical Consulting, Contract Research Organization 23
ICON Plc, Key Competitors 24
ICON Plc, Key Employees 25
ICON Plc, Subsidiaries 26

List Of Figures

List of Figures
ICON Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ICON Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ICON Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
ICON Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
ICON Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
ICON Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
ICON Plc, Medical Devices Deals, 2012 to YTD 2018 10

2018 Diagnostics Competitive Intelligence: ICON Plc Performance, Capabilities, Goals and Strategies

This report is part of the Competitive Analysis Series, which includes current assessments of more than 1,000 companies worldwide. The assessments include all or some of the following: Organization and

USD 950 View Report

Silicon Ranch Corp - Power - Deals and Alliances Profile

Silicon Ranch Corp (Silicon Ranch) develops, owns and operates solar energy plants. The company provides services such as site evaluation, project development, and financing, among others. It caters its services

USD 250 View Report

2018 Diagnostics Competitive Intelligence: ICON Plc Performance, Capabilities, Goals and Strategies

This report is part of the Competitive Analysis Series, which includes current assessments of more than 1,000 companies worldwide. The assessments include all or some of the following: Organization and

USD 950 View Report

ICON Plc: Performance, Capabilities, Goals and Strategies in the Global Diagnostics Market

This report is part of the Competitive Analysis Series prepared by LeadingMarketResearch.com to help current suppliers and potential market entrants realistically assess their financial, technological and marketing capabilities in relation

USD 950 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available